OXIS CURRENT REPORT

Company

GT Biopharma, Inc.

Filed

July 1, 2011

Period of Report

June 27, 2011

Accession Number

0001513160-11-000034

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →